Evidence map›Paper›PMID 32376971›Full record

ArticleBone marrow transplantation2020

High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission.

Matthew J Rees, Andrew Spencer, Peter Browett, Frank Alvaro, Duncan Purtill, Julie Crawford, Sam Milliken, Hock Lai, Humphrey Pullon, Andrew Grigg

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matthew J ReesDepartment of Clinical Haematology, Austin Health, Melbourne, VIC, Australia. Matthew.Rees@austin.org.au.ORCID http://orcid.org/0000-0001-8360-2952
Andrew SpencerMalignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia.
Peter BrowettDepartment of Haematology, Auckland Hospital, Auckland, New Zealand.
Frank AlvaroDepartment of Haematology, John Hunter Children's Hospital, Newcastle, NSW, Australia.
Duncan PurtillDepartment of Haematology, Fiona Stanley Hospital, Perth, WA, Australia.
Julie CrawfordDepartment of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Sam MillikenDepartment of Haematology, St Vincent's Hospital, Sydney, NSW, Australia.
Hock LaiDepartment of Haematology, Townsville Hospital, Townsville, QLD, Australia.
Humphrey PullonDepartment of Haematology, Waikato Hospital, Hamilton, New Zealand.
Andrew GriggDepartment of Clinical Haematology, Austin Health, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteCore Binding FactorsHumansRemission InductionStem Cell TransplantationTransplantation, AutologousCore Binding Factors

Identifiers

PMID32376971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.